Aperiomics, Inc. – Trademark Portfolio

Entity Type: 03

Aperiomics, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 6 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include A, A APERIOMICS, and XPLORE-PATHO. The owner is based in Ashburn, VA.

Suite 305

45085 University Dr.

Ashburn, VA 20147

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Aperiomics, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (6 filings)

Scientific and technological services; industrial analysis and research services

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Aperiomics, Inc. have?

Aperiomics, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 cancelled.

What trademark classes does Aperiomics, Inc. file in?

Aperiomics, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Aperiomics, Inc.'s most well-known trademarks?

Aperiomics, Inc.'s registered trademark portfolio includes well-known marks such as A, A APERIOMICS, and XPLORE-PATHO. These are among 4 currently registered trademarks in the portfolio.

What is Aperiomics, Inc.'s trademark registration success rate?

Aperiomics, Inc. has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.